Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Jul 13 | ESPR | Esperion Therapeutics,… | DTOISS◆ | 21,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 13 | ESPR | Esperion Therapeutics,… | DTOISS | 164,472 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 16 | IRWD | Ironwood Pharmaceuticals… | AGRANT | 63,481 | — | — | +37.0% | Open the original filing on SEC.gov |
| May 28 | ESPR | Esperion Therapeutics,… | AGRANT | 79,873 | — | — | +94.4% | Open the original filing on SEC.gov |
| May 20 | INO | Inovio Pharmaceuticals,… | AGRANT◆ | 34,200 | — | — | — | Open the original filing on SEC.gov |
| May 20 | INO | Inovio Pharmaceuticals,… | AGRANT◆ | 41,800 | — | — | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | IRWD | Ironwood Pharmaceuticals… | AGRANT | 45,000 | — | — | +35.6% | Open the original filing on SEC.gov |
| May 29, 2025 | ESPR | Esperion Therapeutics,… | AGRANT◆ | 44,000 | — | — | — | Open the original filing on SEC.gov |
| May 29, 2025 | ESPR | Esperion Therapeutics,… | AGRANT | 33,000 | — | — | +63.9% | Open the original filing on SEC.gov |
| May 21, 2025 | INO | Inovio Pharmaceuticals,… | MEXER◆ | 2,167 | — | — | — | Open the original filing on SEC.gov |
| May 21, 2025 | INO | Inovio Pharmaceuticals,… | MEXER | 2,167 | — | — | +30.8% | Open the original filing on SEC.gov |